Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
Nafcillin	O
/	O
cefazolin	O
/	O
vancomycin	O
/	O
Bactrim	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Sacral	O
and	O
sacroiliac	O
pain	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None	O
History	O
of	O
Present	O
Illness:	O
Ms.	O
___	O
is	O
a	O
___	O
year	O
old	O
woman	O
with	O
hx	O
significant	O
for	O
DM2,	O
HTN,	O
MSSA	O
bacteremia	O
in	O
___	O
complicated	O
by	O
mitral	O
valve	O
endocarditis	O
as	O
well	O
as	O
sacral	O
and	O
lumbar	O
osteomyelitis,	O
transfered	O
here	O
from	O
___	O
with	O
worsening	O
pain,	O
inability	O
to	O
bear	O
weight	O
and	O
acute	O
renal	O
failure,	O
with	O
creatinine	O
at	O
2.5,	O
up	O
from	O
0.9.	O
She	O
was	O
noted	O
to	O
have	O
worsening	O
ESR	O
and	O
CRP	O
at	O
OSH.	O
MRI	O
was	O
done	O
on	O
___	O
with	O
read	O
still	O
pending.	O
Patient	O
was	O
hospitalized	O
___	O
for	O
progressive	O
lumbar	O
spine	O
osteomyelitis	O
and	O
new	O
sacral	O
osteomyelitis	O
while	O
on	O
linezolid,	O
so	O
Vancomycin	O
was	O
added	O
to	O
her	O
regimen.	O
MRI	O
pelvis	O
showed	O
sacroilitis	O
and	O
involvement	O
of	O
bone	O
and	O
disc	O
space	O
as	O
well	O
as	O
myositis.	O
CT	O
aspiration	O
of	O
SI	O
joint	O
was	O
cx	O
negative.	O
During	O
prior	O
hospitalization,	O
patient	O
had	O
developed	O
delayed	O
hypersensitivity	O
reaction	O
to	O
Nafcillin,	O
so	O
patient	O
was	O
transfered	O
to	O
MICU	O
for	O
Nafcillin	O
densitization	O
protocol.	O
However,	O
she	O
again	O
developed	O
significant	O
delayed	O
hypersensitivy	O
reaction,	O
including	O
severe	O
diffuse	O
maculopapular	O
rash,	O
acute	O
diffuse	O
4+	O
pitting	O
anasarca,	O
a	O
rising	O
eosinophil	O
count	O
with	O
negative	O
urine	O
eosinophils,	O
creatinine	O
bump	O
from	O
0.8	O
to	O
1.8	O
(attributed	O
to	O
acute	O
interstitial	O
nephritis),	O
and	O
severe	O
pulmonary	O
edema.	O
She	O
was	O
treated	O
with	O
prednisone	O
taper	O
and	O
switched	O
back	O
to	O
Vancomycin,	O
when	O
she	O
started	O
to	O
develop	O
a	O
rash	O
and	O
eosinophilia	O
and	O
was	O
thought	O
to	O
be	O
developing	O
acute	O
interstitial	O
nephritis.	O
She	O
was	O
changed	O
to	O
dapto	O
on	O
___.	O
In	O
the	O
ED	O
here,	O
the	O
patient	O
had	O
stable	O
vitals.	O
Labs	O
notable	O
for	O
ESR	O
80,	O
hct	O
25,	O
creatinine	O
2.5.	O
On	O
admission,	O
patient	O
reported	O
___	O
pain	O
in	O
the	O
R	O
ileosacral	O
area,	O
worsening	O
over	O
the	O
past	O
week.	O
She	O
indicates	O
that	O
she	O
can't	O
bear	O
weight	O
at	O
home.	O
She	O
denied	O
any	O
numbness,	O
loss	O
of	O
sensation,	O
pain	O
or	O
difficulty	O
moving	O
her	O
lower	O
extremities.	O
Past	O
Medical	O
History:	O
-	O
Diabetes	O
-	O
Hypertension	O
-	O
Hyperlipidemia	O
-	O
Depression	O
-	O
Restless	O
legs	O
syndrome	O
-	O
MSSA	O
bacteremia,	O
MV	O
endocarditis	O
in	O
___	O
-	O
multiple	O
cervical	O
and	O
lumbar	O
epidural	O
abscesses	O
requiring	O
cervical	O
laminectomies	O
for	O
abscess	O
evacuation	O
in	O
___	O
-	O
septic	O
left	O
shoulder	O
Social	O
History:	O
___	O
Family	O
History:	O
Non-contributory.	O
Physical	O
Exam:	O
ADMISSION	O
EXAM	O
VS:	O
T	O
97.7	O
122/60	O
HR	O
91	O
RR	O
18	O
95RA	O
___:	O
Uncomfortable-appearing	O
F	O
in	O
NAD	O
HEENT:	O
MMM.	O
NECK:	O
Supple,	O
no	O
JVD.	O
HEART:	O
RRR,	O
III/VI	O
systolic	O
murmer	O
best	O
heard	O
at	O
the	O
___.	O
LUNGS:	O
CTA	O
bilat,	O
no	O
r/rh/wh,	O
good	O
air	O
movement,	O
resp	O
unlabored.	O
ABDOMEN:	O
NBS,	O
SNTND	O
EXTREMITIES:	O
WWP,	O
no	O
edema.	O
Eryethematous	O
maculopapular	O
rash	O
on	O
LUE	O
and	O
back.	O
SKIN:	O
B/l	O
sacral	B-Pressure_injury
decub	B-Pressure_injury
pressure	B-Pressure_injury
ulcers,	B-Pressure_injury
stage	O
2.	O
No	O
surrounding	O
erythema.	O
NEURO:	O
Awake,	O
A&Ox3,	B-Delirium
CNs	O
II-XII	O
grossly	O
intact,	O
muscle	O
strength	O
___	O
throughout,	O
sensation	O
grossly	O
intact	O
throughout.	O
DISCHARGE	O
EXAM	O
Physical	O
Exam	O
Vitals:	O
None	O
as	O
patient	O
is	O
CMO	O
Gen:	O
lying	O
in	O
bed	O
in	O
NAD	O
CV:	O
RRR,	O
___	O
holosystolic	O
murmur	O
at	O
___.	O
Resp:	O
CTA	O
bilaterally.	O
No	O
w/r/r	O
Abd:	O
Soft,	O
NT/ND.	O
+BS	O
Ext:	O
WWP	O
Skin:	O
Excoriated	O
erythematous	O
plaques	O
on	O
arms	O
bilaterally	O
Pertinent	O
Results:	O
___	O
ADMISSION	O
CBC:	O
WBC-5.3#	O
RBC-3.00*	O
Hgb-9.1*	O
Hct-26.3*	O
MCV-88	O
MCH-30.2	O
MCHC-34.5	O
RDW-14.4	O
Plt	O
___	O
___	O
LAST	O
CBC:	O
WBC-7.3	O
RBC-2.96*	O
Hgb-9.1*	O
Hct-26.5*	O
MCV-90	O
MCH-30.7	O
MCHC-34.3	O
RDW-14.4	O
Plt	O
___	O
___	O
ESR-70*	O
___	O
CRP-79.2*	O
___	O
ADMISSION	O
CHEM7	O
Glucose-82	O
UreaN-28*	O
Creat-2.6*#	O
Na-140	O
K-4.3	O
Cl-100	O
HCO3-30	O
AnGap-14	O
___	O
LAST	O
CHEM7	O
Glucose-85	O
UreaN-24*	O
Creat-2.2*	O
Na-134	O
K-4.5	O
Cl-102	O
HCO3-23	O
AnGap-14	O
___	O
LFTs	O
ALT-6	O
AST-21	O
LD(LDH)-218	O
CK(CPK)-228*	O
AlkPhos-104	O
TotBili-0.2	O
Brief	O
Hospital	O
Course:	O
Ms.	O
___	O
is	O
a	O
___	O
year	O
old	O
woman	O
who	O
had	O
MSSA	O
bacteremia	O
in	O
___	O
complicated	O
by	O
mitral	O
valve	O
endocarditis	O
and	O
sacral	O
and	O
lumbar	O
osteomyelitis,	O
transfered	O
here	O
from	O
___	O
with	O
osteo	O
and	O
discitis,	O
inability	O
to	O
bear	O
weight,	O
and	O
acute	O
renal	O
failure	O
likely	O
___	O
to	O
antibiotics	O
and	O
NSAID	O
use.	O
She	O
was	O
made	O
"comfort	O
measures	O
only"	O
during	O
this	O
hospitalization.	O
#	O
Sacral	O
and	O
vertebral	O
osteo	O
with	O
discitis	O
Present	O
since	O
hospitalization	O
in	O
___.	O
Pt	O
with	O
severe	O
type	O
IV	O
hypersensitivity	O
reaction	O
to	O
Nafcillin,	O
infx	O
non-reponsive	O
to	O
Vanc,	O
pt	O
developed	O
AIN	O
on	O
Vanc,	O
failed	O
treatment	O
on	O
Dapto.	O
Now	O
with	O
severe	O
bone	O
damage	O
and	O
necrosis	O
from	O
infection.	O
Othropedic	O
and	O
neurosurgery	O
reviewed	O
the	O
case	O
here	O
and	O
offered	O
surgeries	O
with	O
poor	O
prognosis	O
and	O
low	O
likelihood	O
of	O
improving	O
the	O
pt's	O
pain.	O
Infectious	O
disease	O
team	O
did	O
not	O
feel	O
that	O
other	O
antibiotic	O
options	O
were	O
available.	O
Through	O
a	O
process	O
of	O
several	O
family	O
meetings,	O
the	O
patient	O
was	O
made	O
CMO.	O
As	O
her	O
clinical	O
status	O
was	O
stable,	O
the	O
family	O
felt	O
ready	O
for	O
transfer	O
to	O
hospice	O
closer	O
to	O
their	O
home	O
in	O
___.	O
#Pain	O
Was	O
very	O
difficult	O
to	O
control	O
on	O
the	O
patient's	O
MS	O
contin	O
regimen,	O
on	O
which	O
she	O
was	O
requiring	O
high	O
doses	O
of	O
IV	O
dilaudid	O
to	O
get	O
below	O
___	O
pain.	O
She	O
was	O
placed	O
on	O
a	O
dilaudid	O
PCA	O
and	O
was	O
administering	O
more	O
than	O
25mg	O
of	O
dilaudid	O
over	O
each	O
24	O
hours	O
period.	O
With	O
these	O
doses	O
of	O
dilaudid	O
she	O
became	O
quite	O
confused	O
and	O
at	O
time	O
agitated	O
(see	O
below).	O
The	O
patient	O
was	O
then	O
changed	O
to	O
a	O
basal	O
methadone	O
regimen	O
and	O
began	O
requiring	O
much	O
smaller	O
doses	O
of	O
dilaudid.	O
We	O
were	O
able	O
to	O
stop	O
the	O
PCA	O
as	O
the	O
patient	O
was	O
not	O
using	O
it	O
and	O
her	O
confusion	B-Delirium
cleared.	O
She	O
was	O
experiencing	O
good	O
pain	O
control	O
on	O
the	O
basal	O
methdone,	O
with	O
IV	O
dilaudid	O
PRN	O
and	O
neurontin	O
at	O
the	O
time	O
of	O
discharge.	O
She	O
also	O
experienced	O
good	O
response	O
to	O
toradol	O
during	O
the	O
hospitalization,	O
which	O
we	O
have	O
continued	O
as	O
a	O
PRN	O
for	O
severe	O
pain.	O
#Confusion	I-Delirium
Occured	O
in	O
the	O
context	O
of	O
high	O
dose	O
dilaudid.	O
Patient	O
was	O
disorient	B-Unspecified_cognitive_impairment
to	O
everything	O
but	O
self,	O
at	O
times	O
agitated	O
and	O
hallucinating.	B-Visual_impairment
We	O
started	O
PRN	O
olazepine	O
and	O
then	O
haldol	O
for	O
the	O
agitation,	O
though	O
she	O
never	O
required	O
very	O
much	O
of	O
this	O
as	O
the	O
delerium	B-Delirium
resolved	O
with	O
the	O
reduction	O
in	O
dilaudid	O
dose	O
(as	O
above).	O
She	O
experiences	O
good	O
sedative	O
effect	O
from	O
the	O
standing	O
olanzepine	O
at	O
nighttime.	O
#	O
Renal	O
failure	O
Present	O
at	O
arrival	O
with	O
Cr	O
to	O
2.6,	O
likely	O
acute	O
from	O
volume	O
depletion	O
on	O
chronic	O
from	O
AIN	O
and	O
home	O
NSAID	O
use	O
for	O
pain.	O
Cr	O
went	O
back	O
to	O
baseline	O
of	O
1.7,	O
near	O
baseline	O
after	O
administration	O
of	O
fluids.	O
She	O
was	O
given	O
toradol	O
as	O
we	O
attempted	O
to	O
reduce	O
the	O
IV	O
dilaudid	O
dose	O
and	O
she	O
had	O
a	O
Cr	O
or	O
2.2	O
when	O
stopped	O
checking	O
labs	O
on	O
___.	O
#	O
UTI	B-Urinary_tract_infection
Pt	O
reported	O
some	O
dysuria	O
during	O
the	O
hospitalization	O
and	O
had	O
a	O
positive	O
UA.	O
She	O
was	O
treated	O
initially	O
with	O
Bactrim,	O
to	O
which	O
she	O
developed	O
a	O
rash,	O
and	O
then	O
with	O
cipro	O
for	O
a	O
total	O
of	O
3	O
days	O
before	O
she	O
was	O
made	O
CMO	O
an	O
abx	O
were	O
stopped.	O
#	O
Pressure	B-Pressure_injury
ulcers	B-Pressure_injury
Stage	O
2	O
sacral	B-Pressure_injury
pressure	B-Pressure_injury
ulcer	B-Pressure_injury
present	O
at	O
arrival.	O
Wound	O
care	O
bandaged	O
these	O
through	O
the	O
hospitalization.	O
As	O
the	O
patient	O
was	O
experiencing	O
urinary	B-Urinary_incontinence
incontinence,	B-Urinary_incontinence
ulcers	B-Pressure_injury
appeared	O
to	O
be	O
worsening,	O
and	O
bedpan	O
use	O
caused	O
considerable	O
pain,	O
a	O
Foley	O
was	O
placed	O
on	O
___.	O
This	O
is	O
present	O
at	O
the	O
time	O
of	O
DC.	O
TRANSITIONAL	O
ISSUES	O
-We	O
have	O
changed	O
the	O
IV	O
dilaudid	O
to	O
PO	O
for	O
discharge	O
-The	O
patient	O
has	O
a	O
PICC	O
line	O
on	O
the	O
R	O
side	O
which	O
we	O
have	O
left	O
in	O
place	O
for	O
use	O
at	O
hospice	O
-Pt	O
has	O
Foley	O
for	O
urinary	B-Urinary_incontinence
incontinence	B-Urinary_incontinence
in	O
setting	O
of	O
sacral	B-Pressure_injury
decub	B-Pressure_injury
ulcers.	B-Pressure_injury
Medications	O
on	O
Admission:	O
1.	O
Daptomycin	O
430	O
mg	O
IV	O
Q24	O
2.	O
mirtazapine	O
15	O
mg	O
Tablet	O
Sig:	O
0.5	O
Tablet	O
PO	O
HS	O
(at	O
bedtime).	O
3.	O
hydromorphone	O
2	O
mg	O
Tablet	O
Sig:	O
___	O
Tablets	O
PO	O
Q3H	O
(every	O
3	O
hours)	O
as	O
needed	O
for	O
pain.	O
4.	O
simvastatin	O
10	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
5.	O
morphine	O
15	O
mg	O
Tablet	O
Extended	O
Release	O
Sig:One	O
(1)	O
Tablet	O
Extended	O
Release	O
PO	O
Q8H	O
(every	O
8	O
hours).	O
6.furosemide	O
40	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
BID	O
(2	O
times	O
a	O
day).	O
7.	O
Actos	O
15	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
once	O
a	O
day.	O
8.	O
carvedilol	O
12.5	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
once	O
a	O
day.	O
9.	O
carbidopa-levodopa	O
___	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
three	O
times	O
a	O
day.	O
10.	O
metformin	O
500	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
three	O
times	O
a	O
day.	O
11.	O
amitriptyline	O
25	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
three	O
times	O
a	O
day.	O
12.	O
Slowfe	O
slow	O
release	O
iron	O
Fe	O
45mg	O
(FeSulfate	O
143mg)daily	O
13.	O
aspirin	O
81mg	O
Tablet,	O
Chewable	O
Sig:	O
One	O
(1)	O
Tablet,	O
Chewable	O
PO	O
once	O
a	O
day.	O
14.	O
lidocaine	O
patch	O
Sig:	O
One	O
(1)	O
patch	O
once	O
a	O
day:	O
12	O
hours	O
on	O
12	O
hours	O
off.	O
15.	O
Aleve	O
220mg	O
PO	O
BID	O
Discharge	O
Medications:	O
1.	O
Dilaudid	O
4	O
mg	O
Tablet	O
Sig:	O
___	O
Tablets	O
PO	O
Q2H:PRN	O
as	O
needed	O
for	O
pain:	O
Hold	O
for	O
excessive	O
sedation.	O
2.	O
carbidopa-levodopa	O
___	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
TID	O
(3	O
times	O
a	O
day).	O
3.	O
bisacodyl	O
5	O
mg	O
Tablet,	O
Delayed	O
Release	O
(E.C.)	O
Sig:	O
One	O
(1)	O
Tablet,	O
Delayed	O
Release	O
(E.C.)	O
PO	O
DAILY:PRN	O
as	O
needed	O
for	O
constipation.	B-Constipation
4.	O
gabapentin	O
100	O
mg	O
Capsule	O
Sig:	O
One	O
(1)	O
Capsule	O
PO	O
twice	O
a	O
day.	O
5.	O
camphor-menthol	O
0.5-0.5	O
%	O
Lotion	O
Sig:	O
One	O
(1)	O
Appl	O
Topical	O
BID	O
(2	O
times	O
a	O
day)	O
as	O
needed	O
for	O
dry	O
or	O
itchy	O
skin.	O
6.	O
miconazole	O
nitrate	O
2	O
%	O
Powder	O
Sig:	O
One	O
(1)	O
Appl	O
Topical	O
DAILY	O
(Daily).	O
7.	O
methadone	O
5	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
Q8H	O
(every	O
8	O
hours):	O
Hold	O
for	O
excessive	O
sedation.	O
8.	O
polyethylene	O
glycol	O
3350	O
17	O
gram/dose	O
Powder	O
Sig:	O
One	O
(1)	O
dose	O
PO	O
DAILY:	O
PRN	O
as	O
needed	O
for	O
constipation.	B-Constipation
9.	O
acetaminophen	O
500	O
mg	O
Tablet	O
Sig:	O
Two	O
(2)	O
Tablet	O
PO	O
Q	O
8H	O
(Every	O
8	O
Hours):	O
Hold	O
if	O
patient	O
sleeping	O
.	O
10.	O
amitriptyline	O
25	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
TID	O
(3	O
times	O
a	O
day):	O
Hold	O
if	O
pt	O
sleeping.	O
11.	O
olanzapine	O
2.5	O
mg	O
Tablet	O
Sig:	O
Two	O
(2)	O
Tablet	O
PO	O
HS	O
(at	O
bedtime).	O
12.	O
haloperidol	O
0.5	O
mg	O
Tablet	O
Sig:	O
___	O
Tablets	O
PO	O
Q4H	O
(every	O
4	O
hours)	O
as	O
needed	O
for	O
agitation/halluctions/delerium.	O
13.	O
loperamide	O
2	O
mg	O
Capsule	O
Sig:	O
One	O
(1)	O
Capsule	O
PO	O
four	O
times	O
a	O
day	O
as	O
needed	O
for	O
diarrhea.	O
14.	O
Ketorolac	O
15	O
mg	O
IV	O
Sig:	O
One	O
(1)	O
dose	O
Q8H:PRN	O
as	O
needed	O
for	O
Severe	O
pain.	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
Discharge	O
Diagnosis:	O
Primary:	O
Osteomyelitis	O
of	O
the	O
sacrum	O
(infection	O
of	O
the	O
sacral	O
bone)	O
Secondary:	O
Lumbar	O
vertebral	O
osteomyelitis/collapse	O
Urinary	B-Urinary_tract_infection
tract	B-Urinary_tract_infection
infection	B-Urinary_tract_infection
Chronic	O
renal	O
failure	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Confused	B-Delirium
-	O
sometimes.	O
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Bedbound.	B-Bed_Chairbound
Discharge	O
Instructions:	O
Dear	O
___,	O
___	O
was	O
a	O
pleasure	O
to	O
care	O
for	O
you	O
during	O
your	O
stay	O
at	O
the	O
___.	O
You	O
were	O
hospitalized	O
here	O
because	O
you	O
were	O
experiencing	O
worsening	O
pain	O
associated	O
with	O
your	O
bone	O
infection.	O
You	O
were	O
treated	O
with	O
medications	O
for	O
your	O
pain	O
and	O
the	O
options	O
for	O
the	O
treatment	O
of	O
your	O
bone	O
infection	O
were	O
considered.	O
You	O
became	O
confused,	B-Delirium
likely	O
from	O
the	O
pain	O
medications.	O
The	O
surgical	O
doctors	O
discussed	O
treatment	O
options	O
with	O
your	O
family,	O
but	O
the	O
risks	O
of	O
surgery	O
were	O
very	O
high	O
and	O
the	O
surgeons	O
did	O
not	O
feel	O
that	O
the	O
surgeries	O
would	O
eliminate	O
your	O
pain.	O
The	O
Infectious	O
Disease	O
doctors	O
___	O
that	O
there	O
were	O
no	O
other	O
antibiotics	O
that	O
could	O
better	O
treat	O
your	O
infection.	O
While	O
you	O
were	O
very	O
confused,	B-Delirium
your	O
family	O
decided	O
to	O
make	O
your	O
comfort	O
the	O
principle	O
goal	O
of	O
your	O
medical	O
treatment.	O
We	O
changed	O
your	O
pain	O
medications	O
and	O
stopped	O
treatment	O
with	O
antibiotics.	O
Your	O
confusion	B-Delirium
improved	O
on	O
the	O
new	O
pain	O
regimen	O
and	O
you	O
appeared	O
clinically	O
stable.	O
You	O
decided	O
to	O
move	O
to	O
hospice	O
care	O
closer	O
to	O
home	O
and	O
were	O
discharged	O
from	O
___.	O
Your	O
medications	O
have	O
changed	O
since	O
your	O
admission	O
to	O
the	O
hospital.	O
These	O
are	O
your	O
current	O
medications.	O
Please	O
stop	O
taking	O
any	O
medications	O
that	O
are	O
not	O
listed	O
below:	O
1.	O
Dilaudid	O
___	O
mg	O
by	O
mouth	O
as	O
needed	O
for	O
pain.	O
Do	O
not	O
take	O
if	O
excessively	O
sedated.	O
2.	O
Ketorolac	O
15	O
mg	O
IV	O
every	O
eight	O
hours	O
as	O
needed	O
for	O
severe	O
pain.	O
3.	O
Carbidopa-levodopa	O
___	O
mg	O
Tablet	O
three	O
times	O
a	O
day	O
4.	O
Bisacodyl	O
5	O
mg	O
Tablet,	O
Delayed	O
Release	O
(E.C.)	O
One	O
tablet	O
daily	O
as	O
needed	O
for	O
constipation.	B-Constipation
5.	O
Gabapentin	O
100	O
mg	O
Capsule	O
One	O
(1)	O
Capsule	O
by	O
mouth	O
twice	O
a	O
day.	O
6.	O
camphor-menthol	O
0.5-0.5	O
%	O
Lotion	O
one	O
application	O
twice	O
a	O
day	O
as	O
needed	O
for	O
dry	O
or	O
itchy	O
skin.	O
7.	O
miconazole	O
nitrate	O
2	O
%	O
Powder	O
one	O
application	O
daily.	O
8.	O
methadone	O
5	O
mg	O
Tablet	O
by	O
mouth	O
every	O
8	O
hours.	O
Do	O
not	O
take	O
if	O
excessively	O
sedated.	O
9.	O
polyethylene	O
glycol	O
17	O
gram/dose	O
Powder	O
daily	O
as	O
needed	O
for	O
constipation.	B-Constipation
10.	O
acetaminophen	O
1000	O
mg	O
every	O
8	O
hours.	O
11.	O
amitriptyline	O
25	O
mg	O
3	O
times	O
per	O
day.	O
12.	O
olanzapine	O
5	O
mg	O
daily	O
at	O
bedtime.	O
13.	O
haloperidol	O
0.5-1	O
mg	O
every	O
four	O
hours	O
as	O
needed	O
for	O
agitation/halluctions/delerium.	O
14.	O
loperamide	O
2	O
mg	O
Capsule	O
up	O
to	O
four	O
times	O
a	O
day	O
as	O
needed	O
for	O
diarrhea.	O
Followup	O
Instructions:	O
___	O

